If you thought testosterone was only important in men, you'd be mistaken. Adolescent boys with too little testosterone may not experience normal masculinization. The pituitary gland then relays signals to the testes to produce testosterone. Signals sent from the brain to the pituitary gland at the base of the brain control the production of testosterone in men. It is essential to the development of male growth and masculine characteristics. There's more to testosterone than guys behaving badly. For example, did you know that testosterone is a key player in prostate cancer? More research is needed to better understand whether consuming more calcium from food or supplements improves bone health in older adults. Some studies have found that calcium supplements with or without vitamin D increase bone mineral density in older adults, but others do not. The health of your bones is measured with a bone mineral density test, which will tell whether your bones are healthy and strong or weak and thin. Lifestyle factors such as regular exercise, a balanced diet, and adequate intake of vitamin D and calcium also play significant roles in maintaining bone health. There have been no specific RCTs published looking at dual therapy in this population; rather the recommendation stems from the known benefit of both studied in isolation. Following the transition to equal Alendronate treatment, lumbar BMD appeared to plateau with no significant improvement in BMD while the femoral neck BMD continued to improve. Their treatment arms consisted of Alendronate versus placebo for one year followed by Alendronate in both for the next two years. It is not rationalized why a 12-month period of topical treatment followed by a 12-month period of intramuscular treatment was used. Patients were treated with topical testosterone gel for the first 12 months, followed by testosterone intramuscular injection for the remaining 12 months. Long-term bone health is not likely to be affected in people with coeliac disease who consistently stick to a gluten-free diet. Increased osteoporosis risk is due to malabsorption of calcium and other nutrients (and often low body weight). Hyperthyroidism and hyperparathyroidism lead to bone loss and osteoporosis. No menstruation over a long period of time indicates low levels of oestrogen production – a factor which increases the risk of osteoporosis. Once menopause begins your body produces lower levels of oestrogen and the rate of bone loss increases rapidly. Have you ever suffered from impotence, lack of libido or other symptoms related to low testosterone levels? Membership in BHOF will help build your practice, keep your team informed, provide CME credits, and allow you access to key osteoporosis experts. Join our community to learn more about osteoporosis, or connect with others near you who are suffering from the disease. While taking steroids, it is especially important to get enough calcium and vitamin D. Talk with your healthcare provider about taking the lowest dose for the shortest period of time for your condition. Although testosterone may make prostate cancer grow, it is not clear that testosterone treatment actually causes cancer. Affected women may experience low libido, reduced bone strength, poor concentration or depression. As surprising as it may be, women can also be bothered by symptoms of testosterone deficiency. One treatment available for many of these problems is spironolactone, a special type of diuretic (water pill) that blocks the action of male sex hormones. Among women, perhaps the most common cause of a high testosterone level is polycystic ovary syndrome (PCOS). Blood levels of testosterone vary dramatically over time and even during the course of a day. A meta-analysis involving 1083 subjects from 29 randomized controlled studies (RCTs) demonstrated that TRT could improve BMD at the lumbar spine by +3.7% (confidence interval, 1.0%–6.4%) compared with placebo . TRT for hypogonadal men can improve various symptoms (e.g., metabolic syndrome) and has been used worldwide for managing these symptoms and maintaining QOL 2,5. A previous study demonstrated that 12-month administration of aromatase inhibitor in elderly men with hypogonadism resulted in a further decrease in BMD . However, these studies are limited by their small sizes and various potential biases. In particular, this relationship is much stronger in young adult men with moderate to severe hypogonadism 40,41.
